Different Viewpoints: International Perspectives on Newborn Screening.

Area of Science:

• Medical Genetics
• Public Health Policy
• Biochemistry

Background:

• Newborn blood-spot screening is a global public health initiative to detect treatable genetic disorders.
• Significant international variations exist in screening protocols, including disorders screened, technology, consent, and specimen management.

Purpose of the Study:

• To highlight the heterogeneity in global newborn screening practices.
• To identify key policy challenges arising from technological advancements and evolving screening scopes.

Main Methods:

• Comparative analysis of international newborn blood-spot screening guidelines and practices.
• Review of existing legislation and healthcare system integration models.
• Examination of the application of Wilson and Jungner criteria in practice.

Main Results:

• Wide disparities observed in the number of disorders screened, even among countries with similar economic development.
• Lack of consensus on crucial aspects such as parental informed consent, use of DNA mutation analysis, and residual specimen handling.
• Screening practices are influenced by legislative frameworks versus executive management within healthcare systems.

Conclusions:

• Standardized guidelines are needed to address policy gaps in newborn blood-spot screening.
• Future policy development must consider ethical implications and technological advancements, including genomic screening.
• Harmonizing practices is essential for equitable and effective newborn screening programs worldwide.